10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Status:
Recruiting

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.

Clinical Research Computing Unit (University of Pennsylvania)

Pimecrolimus
Tacrolimus